Several studies have shown that activin A is secreted in substantial amounts into the systemic circulation. The changes that occur during menstrual cycle and pregnancy suggest a correlation with reproductive function. At present, however, no definitive evidence has confirmed this pattern throughout adult life; moreover, neither the origin nor the physiological implications of this circulating growth factor have been clearly defined. The aim of the present study was to evaluate whether circulating concentrations of activin A change in adult men and women according to age and sex, and to examine the possible correlation with serum concentrations of FSH. Total dimeric activin A was measured using a specific two-site enzyme immunoassay in serum specimens collected from a cohort of normal individuals enrolled in an epidemiological survey. A group of men (n ¼ 106) and one of women (n ¼ 151) were subdivided into six age groups (20-30, 30-40, 40-50, 50-60, 60-70 and 70-90 years). In a small group of 8 men and 11 women, serum concentrations of activin A were evaluated twice, in specimens collected at an interval of 10 years. Serum FSH concentrations were also measured in all specimens.
Introduction
Activin A is a dimeric protein that was initially isolated and cloned in ovarian follicular fluid (1, 2) . Because its major bioactivity was its capacity to increase the release of follicle-stimulating hormone (FSH) from cultured pituitary cells, it was considered to be a member of the hypothalamus-pituitary-gonadal axis (3) (4) (5) . This hypothesis was in part modified when it was proven that activin A belonged to the transforming growth factor b (TGF-b) family and showed some biological properties of growth factors (6) . Indeed, expression of activin A b-subunit mRNA was found in several organs other than gonads. Organs such as brain, liver, thymus, kidney, adrenal and pituitary gland, placenta and bone marrow produce activin A, and it has been shown to exert a biological effect in them (7, 8) .
Specific assays for detecting activin A in biological fluids have recently been developed (9, 10) and early studies have shown that serum concentrations of dimeric activin A vary slightly throughout the menstrual cycle (11) , and that pregnant women have the greatest serum concentrations (12, 13) . However, while substantial amounts of data indicate that the major source of activin A in pregnancy is the placenta (14) , no clear evidence exists as to the source of activin A in non-pregnant subjects.
The findings of Harada et al. (15) indicated a significant increase in serum activin A in some pathological conditions -hyperthyroidism, chronic renal failure, liver cirrhosis and advanced hard cancers -but this does not help in clarifying the origin of circulating activin A. Furthermore, this study showed that serum concentrations of activin A increase with age, but any relationship with FSH concentrations was not investigated (15) .
The aim of the present study was to evaluate serum concentrations of activin A in a large number of healthy adult men and women over a wide age range, and to investigate possible correlations with serum FSH concentrations.
Patients and methods
Serum samples were collected from two sources. Samples for the age group 30-70 years were obtained from a cohort of individuals enrolled in an epidemiological survey investigating the prevalence and incidence of gallstone disease in Italy (Multicentrica Italiana Colelitiasi -MICOL) (16) . Briefly, the enrolled population completed a questionnaire and underwent physical examination and ultrasonographic screening for the presence of gallstones. This screening was performed in 1984 and repeated in 1993. On both occasions, a blood sample was collected. Among the cohort studied in 1993, we selected 256 serum samples from healthy volunteers (151 women and 106 men), selected on the basis of the following criteria: no clinical history of chronic inflammatory, neoplastic or metabolic diseases; normal biochemical tests and physical examination. None of the subjects was taking medication, and the women were neither pregnant nor using hormonal contraception or hormone replacement therapy. At the 1984 screening, serum samples from only 8 men and 11 women were available and sufficient for analysis.
Serum specimens for the age groups 20-30 and 80-90 years were obtained from a serum bank available in our department. These blood samples were collected between 1993 and 1994 from normal individuals: clinical history, biochemical parameters and physical examination were negative and comparable to those of the MICOL study.
All blood samples, taken after an overnight fast, were left to clot and after centrifugation serum was collected and stored immediately at ¹80 ЊC. Table 1 shows the distribution of the population studied among the different age groups.
Activin A assay
Total concentration of dimeric activin A was measured using a specific two-site enzyme immunoassay as described previously (10, 11) (purchased from Serotec, Oxford, UK). Briefly, in each assay, standard and samples were diluted as appropriate and mixed with an equal volume of distilled water containing 10% SDS. After 3 min at 100 ЊC the tubes were cooled before the addition of a freshly prepared solution of hydrogen peroxide. After an additional period of incubation at room temperature, duplicate aliquots of denatured and oxidized samples/standards were transferred to antibody-coated microtitre plates. These plates were incubated at room temperature, overnight. After washing with a phosphate buffer, 50 ml alkaline phosphataseconjugated extravidin was added, and the plates were incubated for 2 h. The plates were then washed, and bound alkaline phosphatase was quantified by means of a commercially avilable enzyme immunoassay amplification kit (Immuno Select ELISA Amplification System, Dako, Milan, Italy) which was used in accordance with the supplier's instructions. The limit of detection for activin A was 10 pg and the intra-and interassay coefficients of variation (CVs) were 5.0% and 9.0% respectively. The assay crossreacts with activin B, inhibin A, inhibin B, follistatin and a2 macroglobulin by less than 0.5%. 
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FSH assay
Serum concentrations of FSH were determined using the Auto Delphia h-FSH kit (Wallak, Turku, Finland). The assay had a limit of detection of 0.05 U/l; mean intra-and interassay CVs were 3% and 1.5% respectively.
Statistical analysis
The data are expressed as the mean Ϯ S.D., with n indicating the number of samples. Differences between the means in different age groups were analysed by analysis of variance (ANOVA 
Results
Values of serum activin A concentrations in the different age intervals in the total population of men and women studied are illustrated in Table 1 .
As shown in Fig. 1 , in both sexes mean activin A values progressively increased in the first three decades studied (20-30, 30-40 and 40-50 years); furthermore, the mean value of the age group 40-50 years was significantly greater than that found in the age group 20-30 years (P < 0.05). After age 50 years, activin A concentrations in women remained in the same range up to the latest decade (70-90 years), whereas in men the concentrations showed a further increase with age, reaching greatest values at 50-60 years (P < 0.05). Table 1 shows that there were no differences in the mean values of serum concentration of activin A between the two sexes from age 20 to age 50 years. After age 50 up to age 90 years, activin A concentration in men was greater than that in women, when the same age groups were compared (P < 0.01).
When groups were distinguished on the basis of the presence of a regular ovulatory function (data collected from the epidemiological survey questionnaire), serum concentrations of activin A did not appear to differ significantly between fertile (0.57 Ϯ 0.19 ng/ml; n ¼ 38) and postmenopausal women (0.67 Ϯ 0.23 ng/ml; n ¼ 47, from 3 to 10 years of amenorrhea).
A direct relationship between age and activin A concentrations was found in men, but not in women (Fig. 2) , whereas no correlation between serum activin A and FSH concentrations was found in either men (Fig.  3a) or women (Fig. 3b) .
Longitudinal evaluation on serum samples collected ten years apart in 19 individuals showed that activin A concentrations increased with advancing age in men (n ¼ 8; 0.65 Ϯ 0.14 compared with 0.98 Ϯ 0.19; P < 0.02), but not in women (n ¼ 11; 0.66 Ϯ 0.31 compared with 0.62 Ϯ 0.10; NS) (Fig. 4) .
Discussion
This study has demonstrated for the first time that normal men from the age of 50 years onwards have greater serum concentrations of activin A than have age-matched women. From this age, serum concentrations of activin A in men remain significantly greater than those in women until the age of 90 years. Mean values in men during the last three decades are two-to threefold greater than in the 20-30-year age group. Our findings are partly in accordance with those presented by Harada et al. (15) , who demonstrated an age-related increase in serum activin A concentrations in both men and women. However, whereas in this study no difference was found between men and women in the age-related variation in activin A concentration, we have found that serum activin A concentrations were greater in men than in women, reaching a statistically significant difference after the age of 50 years. These variations may be due to the different assay adopted, or to the different number of subjects included in each age group in the two studies. In this regard, it may be hypothesized that the lower number of samples per age group examined in the study by Harada et al. (15) , could have concealed the age-related variation, because of the high variability of serum activin A concentrations in humans in different age groups.
The question that remains unanswered concerns the possible source(s) of circulating activin A. Even though it is generally accepted that inhibin A and inhibin B have a testicular origin in men (17, 18) and an ovarian origin in women (17, (19) (20) (21) , the present findings seem to exclude this hypothesis for activin A. Our study did, indeed, show that serum concentrations of activin A in men and women are not related to FSH concentration throughout adult life; furthermore, no differences exist between fertile and postmenopausal women. It has been proven that serum inhibin concentrations become undetectable in postmenopausal women (22) . These findings clearly suggest that gonads are therefore not the major source of circulating activin A in both sexes. This conclusion does not contradict the finding by Muttukrishna et al. (11) of biphasic changes in serum activin A concentrations at midcycle and early follicular and late luteal phases, thus suggesting that activin A has an important role in the recruitment of follicles for the subsequent cycle. Indeed, in the study by Muttukrishna et al. (11) , activin A concentrations showed no correlation with FSH, luteinizing hormone, oestradiol or progesterone concentrations. A correlation with variations in the reproductive function may explain the greater concentrations of activin A in women aged between 40 and 50 years. During this ten-year period, ovarian activity undergoes a significant decrease as a result of a slight but significant increase in secretion of FSH (23, 24) and therefore the increased concentrations of activin A may be induced by the alterations occurring in reproductive ageing. Evidence that serum concentrations of follistatin, the binding protein for circulating activin A, do not vary with reproductive function (puberty, menstrual cycle, menopause) or hormones (FSH, estradiol) indirectly suggests that the circulating concentrations of activin A have no direct influence on reproductive function (25) (26) (27) .
Our study does clearly exclude a major gonadal origin of circulating activin A, but does not provide an answer to the major question of its possible source(s). The evidence of an age-related increase in concentrations of activin A in men does not suggest any specific hypothesis. Both the large number of organs that express activin A, and multiple target functions lead to a variety of different hypotheses. Nevertheless, the possible candidates as its source -such as pituitary, adrenal cortex, liver, blood vessels or bone marrow -do not show any significant sex-related variation during the ageing processes. The increased concentrations of circulating activin A in systemic diseases and in hard or hematological malignancies (15) , associated with increased concentrations of serum follistatin (27) , suggest that the secretion of these proteins is most probably part of a systemic homeostatic reaction, and thus reflects a series of local paracrine/autocrine events that occur in the various organs.
The evidence that activin A circulates with a sex-and age-related concentration profile is clearly the major outcome of the present study; however, its origin and the physiological implications remain to be elucidated in further studies. 
